Cash & equivalents decreased 25.4%
Cash & equivalents changed -25.4% from the comparable as-filed period.
Ranked by interpretable importance, issuer history, magnitude, and accounting profile. No directional recommendation.
Cash & equivalents changed -25.4% from the comparable as-filed period.
Net income changed +46.9% from the comparable as-filed period.
Operating income changed +24.4% from the comparable as-filed period.
Inventory changed -13.0% from the comparable as-filed period.
Gross profit changed +5.1% from the comparable as-filed period.
Operating margin changed +144 basis points from the comparable as-filed period.
Revenue changed +6.1% from the comparable as-filed period.
Stock-based compensation changed +7.4% from the comparable as-filed period.
Gross margin changed -35 basis points from the comparable as-filed period.
Research & development changed +3.6% from the comparable as-filed period.
Selling, general & administrative changed -0.2% from the comparable as-filed period.
Method Importance combines metric-family relevance, magnitude, issuer-history unusualness, persistence, and financial-statement significance. It is analytical prioritization, not a legal materiality conclusion or investment signal.